4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-22-000032
Chief Executive Officer acquired 103,469 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hively Brad Chief Executive Officer | 2022-11-17 | Grant or award | +103,469 | 555,670 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hively Brad Chief Executive Officer | 2022-11-17 | Grant or award · Non-Qualified Stock Option (right to buy) | +525,188 | 525,188 | D: show line 2 in the form |
Loading xslF345X03/edgardoc.xml…